Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.
Therapy-related acute myeloid leukemia (t-AML) in most cases develops after chemotherapy of other malignancies and shows characteristic chromosome aberrations. Two general types of t-AML have previously been identified. One type is observed after therapy with alkylating agents and characteristically...
Main Authors: | Pedersen-Bjergaard, J, Andersen, M, Christiansen, D, Nerlov, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
by: Ugo Testa, et al.
Published: (2023-06-01) -
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
by: Milan Jagurinoski, et al.
Published: (2023-10-01) -
Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report
by: Xian-Fu Sheng, et al.
Published: (2022-09-01) -
Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases
by: Yenny Alejandra Moreno Vanegas, et al.
Published: (2018-09-01) -
Therapy-related leukemia and myelodysplasia: susceptibility and incidence
by: Giuseppe Leone, et al.
Published: (2007-10-01)